Physician profile
Yehuda E Kleinman
NPI 1043210156
$18,024.98
in general payments reported to CMS, 2019-2025
10 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.09 · 2020: $126 · 2021: $17K · 2022: $76.96 · 2023: $257 · 2024: $63.33 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $17,172.00 | 2021 | |
| Stryker Corporation | $290.28 | 2023-2025 | Alphavent, Iconix |
| Fidia Pharma USA INC. | $168.87 | 2019-2025 | Triluron, Hymovis, Hyalgan |
| Pfizer INC. | $125.64 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $82.73 | 2023 | Tricera Handpiece |
| Horizon Therapeutics Plc | $63.86 | 2020-2022 | |
| Depuy Synthes Sales INC. | $50.50 | 2019-2024 | Orthovisc |
| Ferring Pharmaceuticals INC. | $29.40 | 2019-2020 | |
| Ibsa Pharma INC. | $22.26 | 2022 | |
| Bioventus LLC | $19.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yehuda Kleinman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.